Kenneth W. Hance

3.1k total citations · 2 hit papers
28 papers, 2.4k citations indexed

About

Kenneth W. Hance is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Kenneth W. Hance has authored 28 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 10 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Kenneth W. Hance's work include Immunotherapy and Immune Responses (12 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immune Cell Function and Interaction (6 papers). Kenneth W. Hance is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immune Cell Function and Interaction (6 papers). Kenneth W. Hance collaborates with scholars based in United States, Italy and Malaysia. Kenneth W. Hance's co-authors include William F. Anderson, Paul H. Levine, John W. Greiner, Jeffrey Schlom, Connie J. Rogers, David A. Zaharoff, Susan S. Devesa, Heather A. Young, Patrick A. Mayes and Axel Hoos and has published in prestigious journals such as The Journal of Immunology, Nature Reviews Drug Discovery and JNCI Journal of the National Cancer Institute.

In The Last Decade

Kenneth W. Hance

27 papers receiving 2.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trends in Inflammatory Breast Carcinoma Incidence and Survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute

2005 500 citations Kenneth W. Hance, William F. Anderson et al. JNCI Journal of the National Cancer Institute profile →
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β

2018 405 citations Yan Lan, Dong Zhang et al. Science Translational Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Kenneth W. Hance	1.2k	898	626	508	292	28	2.4k
Marta L. Corcoran	706 0.6×	548 0.6×	765 1.2×	968 1.9×	66 0.2×	27	2.5k
Sabine Middendorp	888 0.7×	1.0k 1.1×	1.1k 1.7×	151 0.3×	303 1.0×	37	3.0k
Jamila Louahed	1.3k 1.1×	2.2k 2.4×	788 1.3×	173 0.3×	190 0.7×	59	3.4k
Michael Geißler	1.5k 1.2×	818 0.9×	775 1.2×	352 0.7×	352 1.2×	151	3.5k
Pascal Descargues	438 0.4×	854 1.0×	843 1.3×	354 0.7×	124 0.4×	29	2.8k
Tahseen H. Nasti	2.6k 2.1×	2.6k 3.0×	877 1.4×	311 0.6×	122 0.4×	58	4.4k
Hilmar Berger	797 0.7×	372 0.4×	1.1k 1.8×	443 0.9×	245 0.8×	50	2.7k
Naohiro Seo	612 0.5×	1.4k 1.5×	713 1.1×	287 0.6×	132 0.5×	77	2.4k
Marie‐Pierre Buisine	750 0.6×	528 0.6×	1.9k 3.0×	344 0.7×	516 1.8×	79	3.1k

Countries citing papers authored by Kenneth W. Hance

Since Specialization

Citations

This map shows the geographic impact of Kenneth W. Hance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth W. Hance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth W. Hance more than expected).

Fields of papers citing papers by Kenneth W. Hance

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth W. Hance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth W. Hance. The network helps show where Kenneth W. Hance may publish in the future.

Co-authorship network of co-authors of Kenneth W. Hance

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth W. Hance. A scholar is included among the top collaborators of Kenneth W. Hance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth W. Hance. Kenneth W. Hance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lan, Yan, Dong Zhang, Chunxiao Xu, et al.. (2018). Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β. Science Translational Medicine. 10(424). 405 indexed citations breakdown →

Mayes, Patrick A., Kenneth W. Hance, & Axel Hoos. (2018). The promise and challenges of immune agonist antibody development in cancer. Nature Reviews Drug Discovery. 17(7). 509–527. 276 indexed citations

Waight, Jeremy D., Shinji Takai, Bo Marelli, et al.. (2014). Cutting Edge: Epigenetic Regulation of Foxp3 Defines a Stable Population of CD4+ Regulatory T Cells in Tumors from Mice and Humans. The Journal of Immunology. 194(3). 878–882. 47 indexed citations

Zaharoff, David A., Kenneth W. Hance, Connie J. Rogers, Jeffrey Schlom, & John W. Greiner. (2010). Intratumoral Immunotherapy of Established Solid Tumors With Chitosan/IL-12. Journal of Immunotherapy. 33(7). 697–705. 79 indexed citations

Vergati, Matteo, Vittore Cereda, Ravi A. Madan, et al.. (2010). Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination. Cancer Immunology Immunotherapy. 60(2). 197–206. 46 indexed citations

Hance, Kenneth W., Connie J. Rogers, David A. Zaharoff, et al.. (2009). The Antitumor and Immunoadjuvant Effects of IFN-α in Combination with Recombinant Poxvirus Vaccines. Clinical Cancer Research. 15(7). 2387–2396. 21 indexed citations

Zaharoff, David A., Compton J. Benjamin, Kiranpreet Khurana, et al.. (2009). Intravesical Immunotherapy of Superficial Bladder Cancer with Chitosan/Interleukin-12. Cancer Research. 69(15). 6192–6199. 87 indexed citations

Rogers, Connie J., Kenneth W. Hance, David A. Zaharoff, et al.. (2008). Exercise, alone and in combination with an anti-CEA vaccine, reduces pancreatic tumor cell growth and enhances survival in mice.. Cancer Research. 68. 2096–2096. 2 indexed citations

Rogers, Connie J., David Berrigan, David A. Zaharoff, et al.. (2008). Energy Restriction and Exercise Differentially Enhance Components of Systemic and Mucosal Immunity in Mice. Journal of Nutrition. 138(1). 115–122. 29 indexed citations

10.

Cui, Min, Yan Zhao, Kenneth W. Hance, et al.. (2008). Effects of MAPK signaling on 1,25‐dihydroxyvitamin D‐mediated CYP24 gene expression in the enterocyte‐like cell line, Caco‐2. Journal of Cellular Physiology. 219(1). 132–142. 40 indexed citations

11.

Rogers, Connie J., David A. Zaharoff, Kenneth W. Hance, et al.. (2008). Exercise enhances vaccine-induced antigen-specific T cell responses. Vaccine. 26(42). 5407–5415. 27 indexed citations

12.

Wansley, Elizabeth K., Mala Chakraborty, Kenneth W. Hance, et al.. (2007). Vaccination of CEA-transgenic mice with a recombinant Saccharomyces cerevisiae-CEA vaccine breaks immune tolerance and elicits therapeutic antitumor responses. Molecular Cancer Therapeutics. 6. 1 indexed citations

13.

Zaharoff, David A., Connie J. Rogers, Kenneth W. Hance, Jeffrey Schlom, & John W. Greiner. (2007). Chitosan solution enhances the immunoadjuvant properties of GM-CSF. Vaccine. 25(52). 8673–8686. 52 indexed citations

14.

Hance, Kenneth W., Connie J. Rogers, David A. Zaharoff, et al.. (2006). Diet-induced obesity promotes pancreatic tumor growth in mice.. Cancer Epidemiology and Prevention Biomarkers. 15. 1 indexed citations

15.

Rogers, Connie J., Kenneth W. Hance, David A. Zaharoff, et al.. (2006). Diet-induced obesity impairs both innate and adaptive immune responses.. Cancer Epidemiology and Prevention Biomarkers. 15. 1 indexed citations

16.

Zaharoff, David A., Connie J. Rogers, Kenneth W. Hance, Jeffrey Schlom, & John W. Greiner. (2006). Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine. 25(11). 2085–2094. 301 indexed citations

17.

Kłopot, Anna, Kenneth W. Hance, Sara Peleg, Julia Bársony, & James C. Fleet. (2006). Nucleo‐cytoplasmic cycling of the vitamin D receptor in the enterocyte‐like cell line, Caco‐2. Journal of Cellular Biochemistry. 100(3). 617–628. 18 indexed citations

18.

Hance, Kenneth W., Hasan E. Zeytin, & John W. Greiner. (2005). Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: Evaluation of CEA-based cancer vaccines. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 576(1-2). 132–154. 26 indexed citations

19.

Hance, Kenneth W., William F. Anderson, Susan S. Devesa, Heather A. Young, & Paul H. Levine. (2005). Trends in Inflammatory Breast Carcinoma Incidence and Survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute. JNCI Journal of the National Cancer Institute. 97(13). 966–975. 500 indexed citations breakdown →

20.

Sun, Juan, Susan Fosmire, Kenneth W. Hance, et al.. (2003). Enhancing antimelanoma immune responses through apoptosis. Cancer Gene Therapy. 10(9). 726–736. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact